Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors
Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors
复制标题
DOI:
10.1016/j.ejrad.2006.08.014
复制
发表时间:
2007-01-01
影响因子:
3.3
通讯作者:
Shiratori, Yasushi
中科院分区:
文献类型:
--
作者:
Okamoto, Yuko;Kawamoto, Hirofumi;Shiratori, Yasushi
Objective: The aim of this study is to evaluate the efficacy of contrast-enhanced ultrasonography for the diagnosis of pancreatic tumors.Materials and methods: Contrast-enhanced ultrasonography with Levovist was performed on 62 consecutive patients (53 with pancreatic cancer, 4 with islet cell tumor, 3 with inflammatory pancreatic tumor, and 2 with metastatic tumor). The vascular and perfusion image phases of the tumors were evaluated and compared with the findings of contrast-enhanced computed tomography.Results: Contrast-enhanced ultrasonography showed tumor vessels around and/or in the tumor at the vascular image phase in 79% of pancreatic cancer patients (42/53). At the perfusion image phase, 96% of pancreatic cancers (51/53) were classified as hypo-enhancement type. However, tiny spotty or irregular heterogeneous enhanced lesions were found in 84% of hypo-enhanced pancreatic cancer patients (43/51). The presence of small vessels at the vascular image phase was closely correlated with the presence of these intratumor regional enhanced lesions at the perfusion image phase (K coefficient = 0.42). The sensitivity of contrast-enhanced ultrasonography (100%) for pancreatic cancer was superior to that of contrast-enhanced computed tomography (91%), but no significant difference was observed between the two (McNemar test: p = 0.063).Conclusion: Contrast-enhanced ultrasonography with Levovist successfully visualizes fine vessels and enhancement in pancreatic tumors, and is useful for evaluating pancreatic tumors. (C) 2006 Elsevier Ireland Ltd. All rights reserved.